Physicians Realty Trust Announces 2022 GRESB Survey Rating
Demonstrates continuing ESG transparency by earning a score of 75 out of 100 in the 2022 Real Estate Assessment and a Public Disclosure Level score of 98 out of 100
The GRESB Public Disclosure Level is an overall measure of ESG disclosure by listed property companies based on a selection of indicators aligned with the existing GRESB Real Estate Assessment. The Public Disclosure Level provides insight into the ESG disclosure activities of both GRESB participants and non-participants. It offers investors insights currently not captured in the GRESB Real Estate Assessment.
Each year, GRESB assesses and benchmarks the ESG performance of real estate and infrastructure assets worldwide, providing clarity and insights to financial markets on complex sustainability topics. In 2022, the GRESB ESG Benchmark grew to cover more than
“This year’s participation growth across the real estate and infrastructure benchmarks underscores the continued and unwavering commitment of the global real assets industry to ESG transparency and sustainability,” shared Sebastien Roussotte, CEO of GRESB.
“Our annual GRESB Real Estate Assessment efforts and continued high scores celebrate the leadership and contributions of our entire team, demonstrating the success of our actions to date,” said
Learn more about DOC’s sustainability efforts in our latest annual ESG Report at www.docreit.com/esg.
About GRESB
GRESB is a mission-driven and industry-led organization providing standardized and validated Environmental, Social, and Governance (ESG) data to financial markets. Established in 2009, GRESB has become the leading ESG benchmark for real estate and infrastructure investments worldwide, used by more than 170 institutional and financial investors to inform decision-making. For more information, visit GRESB.com.
About
Forward-Looking Statements
This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, “continue”, “intend”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward looking statements may include statements regarding the Company’s strategic and operational plans, the Company’s ability to generate internal and external growth, the future outlook, anticipated cash returns, cap rates or yields on properties, anticipated closing of property acquisitions, ability to execute its business plan, and the impact of the COVID-19 pandemic on the Company’s business. While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward looking statements. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual results to differ materially from such statements. These risks and uncertainties are described in greater detail in the Company’s filings with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20221018006213/en/
President and CEO
(214) 549-6611
jtt@docreit.com
Executive Vice President and CFO
(414) 367-5610
jnt@docreit.com
Source: